NCT00277394 - Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis | Biotech Hunter

Enrollment

541

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

July 31, 2008

Conditions

Deep Vein Thrombosis

Interventions

DRUG

innohep®

175 anti-Xa IU/kg administered subcutaneously (SC) once daily

DRUG

Heparin

Heparin 50 IU /kg followed by a total dose of 400 to 600 IU/kg/day divided into two SC injections daily.

Trial Locations (9)

Clinical Center Serbia, Institute of Cardiovascular diseases & Centre for Vascular Surgery-Belgrade, Belgrade

Service of Geriatry, Hospital Universitario Clínico San Carlos, Madrid

Hôpital de la Cavale Blanche, Brest

Med. Klinik IV/Klinikum Darmstadt, Darmstadt

Bulgaria - managed by CRO, Sofia

Croatia - managed by CRO, Zagreb

Czech Republic - managed by CRO, Prague

Klinika Chirugii Naczyniowej, Szczecin

Romania - managed by CRO, Bucharest